Taken together, these data suggested that ZVI@CMC could sensitize ESCC cells to radiation treatment due to recovery of SOX17/NRF2 axis, and combination treatment could serve as a promising strategy to overcome CCRT resistance in SOX17low/NRF2high cancer cells. Here, NFE2L2 is linked to esophageal squamous cell carcinoma.